Tweet Tracking: A Must For Companies’ Adverse Event Oversight?

Regulatory experts disagree on how actively device and drug companies should be monitoring social media sites for information on adverse events.

Industry attorneys and regulatory consultants disagree on how actively device and drug companies should be monitoring social media websites, such as Twitter, Facebook and YouTube, for discussion of product-related adverse events.

While FDA says regulations do not require broad, proactive monitoring of the Web, the agency notes that companies are expected...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet